A BILL 
To amend title XVIII of the Social Security Act to provide 
for certain amendments relating to reporting require-
ments with respect to clinical diagnostic laboratory tests, 
and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Laboratory Access for 
4
Beneficiaries Act’’ or the ‘‘LAB Act’’. 
5
23:49 Jul 09, 2019
H3584
2 
•HR 3584 IH
SEC. 2. AMENDMENTS RELATING TO REPORTING REQUIRE-
1
MENTS WITH RESPECT TO CLINICAL DIAG-
2
NOSTIC LABORATORY TESTS. 
3
(a) REVISED REPORTING PERIOD FOR REPORTING 
4
OF PRIVATE SECTOR PAYMENT RATES FOR ESTABLISH-
5
MENT
OF
MEDICARE
PAYMENT
RATES.—Section 
6
1834A(a) of the Social Security Act (42 U.S.C. 1395m– 
7
1(a)) is amended— 
8
(1) in paragraph (1)— 
9
(A) by striking ‘‘Beginning January 1, 
10
2016’’ and inserting the following: 
11
‘‘(A) 
GENERAL
REPORTING
REQUIRE-
12
MENTS.—Subject to subparagraph (B), begin-
13
ning January 1, 2016’’; and 
14
(B) by adding at the end the following: 
15
‘‘(B) REVISED
REPORTING
PERIOD.—In 
16
the case of reporting with respect to clinical di-
17
agnostic laboratory tests that are not advanced 
18
diagnostic laboratory tests, the Secretary shall 
19
revise the reporting period under subparagraph 
20
(A) such that— 
21
‘‘(i) no reporting is required during 
22
the period beginning January 1, 2020, and 
23
ending January 1, 2021; 
24
23:49 Jul 09, 2019
H3584
3 
•HR 3584 IH
‘‘(ii) reporting is required during the 
1
period beginning January 1, 2021, and 
2
ending March 31, 2021; and 
3
‘‘(iii) reporting is required every three 
4
years after the period described in clause 
5
(ii).’’; and 
6
(2) in paragraph (4)— 
7
(A) by striking ‘‘In this section’’ and in-
8
serting the following: 
9
‘‘(A) IN
GENERAL.—Subject to subpara-
10
graph (B), in this section’’; and 
11
(B) by adding at the end the following: 
12
‘‘(B) EXCEPTION.—In the case of report-
13
ing during the period described in paragraph 
14
(1)(B)(ii) with respect to clinical diagnostic lab-
15
oratory tests that are not advanced diagnostic 
16
laboratory tests, the term ‘data collection pe-
17
riod’ means the period beginning January 1, 
18
2019, and ending June 30, 2019.’’. 
19
(b) CORRECTIONS RELATING TO PHASE-IN OF RE-
20
DUCTIONS FROM PRIVATE PAYOR RATE IMPLEMENTA-
21
TION.—Section 1834A(b)(3) of the Social Security Act 
22
(42 U.S.C. 1395m–1(b)(3)) is amended— 
23
(1) in subparagraph (A), by striking ‘‘through 
24
2022’’ and inserting ‘‘through 2023’’; and 
25
23:49 Jul 09, 2019
H3584
4 
•HR 3584 IH
(2) in subparagraph (B)— 
1
(A) in clause (i), by striking ‘‘through 
2
2019’’ and inserting ‘‘through 2020’’; and 
3
(B) in clause (ii), by striking ‘‘2020 
4
through 2022’’ and inserting ‘‘2021 through 
5
2023’’. 
6
SEC. 3. STUDY AND REPORT BY NATIONAL ACADEMY OF 
7
MEDICINE. 
8
(a) IN GENERAL.—Not later than 90 days after the 
9
date of the enactment of this Act, the Administrator of 
10
the Centers for Medicare & Medicaid Services (referred to 
11
in this section as the ‘‘Administrator’’) shall enter into an 
12
agreement with the National Academies of Sciences, Engi-
13
neering, and Medicine (referred to in this section as the 
14
‘‘National Academies’’) to conduct a study to review the 
15
methodology the Administrator has implemented for the 
16
private payor rate-based clinical laboratory fee schedule 
17
under the Medicare program under title XVIII of the So-
18
cial Security Act (42 U.S.C. 1395 et seq.). 
19
(b) SCOPE OF STUDY.—In carrying out the study de-
20
scribed in subsection (a), the National Academies shall 
21
consider the following: 
22
(1) How best to implement the least burden-
23
some data collection process required under section 
24
23:49 Jul 09, 2019
H3584
5 
•HR 3584 IH
1834A(a)(1) of such Act (42 U.S.C. 1395m–1(a)(1)) 
1
that would— 
2
(A) result in a representative and statis-
3
tically valid data sample of private market rates 
4
from all laboratory market segments, including 
5
hospital outreach laboratories, physician office 
6
laboratories, and independent laboratories; and 
7
(B) consider the variability of market seg-
8
ments by laboratory procedure code. 
9
(2) Appropriate statistical methods for esti-
10
mating rates that are representative of the market. 
11
(c) REPORT TO CONGRESS.—Not later than the date 
12
that is 18 months after the Administrator enters into the 
13
agreement described in subsection (a) with the National 
14
Academies, the National Academies shall submit to the 
15
Administrator, the Committee on Finance of the Senate, 
16
and the Committees on Ways and Means and Energy and 
17
Commerce of the House of Representatives a report that 
18
includes— 
19
(1) conclusions about the methodology de-
20
scribed in such subsection; and 
21
(2) recommendations on ways to improve such 
22
methodology. 
23
Æ 
23:49 Jul 09, 2019
H3584
